TY  - JOUR
AU  - Lozano Borregón, Daniel
AU  - Leiva, Beatriz
AU  - Gómez-Escalonilla, Inés
AU  - Portal Núñez, Sergio
AU  - Gortázar, Arancha R.
AU  - Manzano García, Miguel
AU  - Vallet Regí, María Dulce Nombre
PY  - 2023
DO  - 10.3390/pharmaceutics15020658
SN  - 1999-4923
UR  - https://hdl.handle.net/20.500.14352/73414
T2  - Pharmaceutics
AB  - Osteoporosis is the most common type of bone disease. Conventional treatments are based on the use of antiresorptive drugs and/or anabolic agents. However, these treatments have certain limitations, such as a lack of bioavailability or toxicity in...
LA  - eng
M2  - 658
PB  - MDPI
KW  - Nanoparticles
KW  - Mesoporous materials
KW  - Pleiotrophin
KW  - Osteoporosis
KW  - Osteoblasts
KW  - Stem cells
KW  - Polyethylenimine
KW  - Osteogenic
TI  - Pleiotrophin-Loaded Mesoporous Silica Nanoparticles as aPossible Treatment for Osteoporosis
TY  - journal article
VL  - 15
ER  -